Who Should I Start? Rashee Rice or Keon Coleman

Friday, September 6, 12:07 PM

Kansas City Chiefs wide receiver Rashee Rice will likely not miss any time during the 2024 season as he awaits a trial date for his felony charges of street racing, according to Mike Florio of Pro Football Talk. Florio reports that a guilty plea in 2024 is unlikely as Rice has no official trial date. Florio's sources express that since the trial will not happen until December (at the earliest), there is no urgency to reach a plea deal. Florio further emphasized that Rice will likely be suspended at some time, but it is hard to picture that he will miss time this season. Fantasy managers who have Rice on their team should continue to follow any updates regarding his legal issues throughout the season in case he does miss time. After being a league-winner down the stretch last season, the 24-year-old continued his breakout run by catching seven passes for 103 yards in the season opener on Thursday. Rice should continue to be a lineup lock for the foreseeable future as he is shaping up to be Patrick Mahomes' go-to option in the passing game.

Friday, September 6, 11:16 AM

How will the target share be spread out in Buffalo? That's the question many fantasy managers are asking as we approach the Bills' season opener. Tight end Dalton Kincaid is projected to lead the team, with receivers Keon Coleman, Khalil Shakir, and Curtis Samuel not far behind. Coleman, a second-round pick, is unlike the other two receivers. He's a big body who can develop into a deep threat. He struggles with separation, an issue that could impact him early, even against a weak Arizona secondary. The key is whether Josh Allen and the rookie have developed enough chemistry and timing to get the football where Coleman can make a play. It wouldn't be a big surprise to see Coleman break off a long reception in his NFL debut, but it's a risky gamble. It's safer for fantasy managers to watch how the target and snap shares shake out before inserting Coleman into starting lineups.